IL-2, a lymphokine secreted by T cells that functions in the growth and differentiation of lymphocytes and monocytes, binds to a 55-kD glycoprotein (p55), designated CD25, with low affinity (N10-40 nM kD) and a 70-75 kD glycoprotein (p75) with an intermediate affinity (-1-5 nM kD) (1) (2) (3) (4) . The high affinity IL-2 receptor (-10-30 pM kD) is composed of noncovalently associated p55 and p75 subunits (1) (2) (3) (4) . Several laboratories have generated mAbs against the p55 and p75 IL-2 binding proteins (5, 6) , thus allowing for the detection of these receptors on leukocyte populations .
NK cells are a distinct population of CD3e -,CD56 + lymphocytes that do not rearrange or express TCR genes and are characterized by their ability to mediate MHCunrestricted cytotoxicity against a variety of tumor-and virus-infected cell lines (7) . IL-2 directly activates NK cells, resulting in proliferation and the induction of cytotoxic activity (8) (9) (10) . The majority of peripheral blood CD16+ NK cells constitutively express the p75 IL-2R, and mAbs against p75 IL-2R efficiently block IL-2-dependent functions, suggesting that the p75 IL-2R is the predominant IL-2 binding structure on resting NK cells (11) . We have previously reported that two subsets of NK cells can be identified based on expression of CD16 (FcR-yIII) . Whereas most peripheral blood NK cells express the phenotype CD16+,CD56 + , a minor subset of NK cells are CD16-,CD56+ (referred to as CD16 -NK cells) (12, 13) . Neither of these subsets expresses CD3e or rearranges TCR genes, but both mediate NK cytotoxic function and express many similar phenotypic characteristics (12, 13) . In the present study, we demonstrate that CD16-NK cells constitutively express high affinity IL-2 receptors in vivo and preferentially respond to low amounts of IL-2 .
Materials and Methods
Cell Purification and Culture. PBMC were isolated by Ficoll/Hypaque centrifugation . After plastic adherence and passage through nylon wool, NK cells were enriched by centrifugation on discontinuous gradients ofPercoll (Pharmacia Fine Chemicals, Piscataway, NJ) (10 Immunofluorescence and Flow Cytometry . Immunofluorescence and flow cytometry were performed as previously described (10) . Cells were analyzed on a FACScan, and cell sorting was performed on a FACStar or FAGS IV (Becton Dickinson Immunocytometry Systems, San Jose, CA) .
Cytotoxicity Assay. Cell-mediated cytotoxicity was measured in a 4-h "Cr-release assay (10). IL-2 Binding Assay. IL-2 binding assays and Scatchard analysis were performed as previously described (14) . All reagents for the binding assays were generously provided by Dr. Kendall Smith (Dartmouth Medical School, Hanover, NH).
Results and Discussion
Expression ofp75 and p55 IL-2 Receptors on CD16-and CD16' NK Cells . PBL enriched for NK cells using Percoll density gradients were stained with FITC anti-CD56 and PE anti-CD25 or PE anti-p75 IL-2R and analyzed by two-color immunofluorescence . As previously reported (12) , the majority of circulating resting NK cells express low surface density CD56 and high surface density CD16 (CD16+ CD56d'°" NK cells). A small subset of NK cells do not express CD16, but have significantly higher surface density CD56 (CD16 -CD56b"ght' NK cells) . Neither of these NK cell subsets express CD3 (12) . Based on analysis of more than 20 normal donors, both CD16-CD56br'gh' and CD16+CD56d""+ NK cell subsets expressed the p75 IL-2R; however, only the CD16-CD56br'ghc+ NK cells constitutively expressed detectable CD25 (Fig. 1) . The finding that the major subset of NK cells (CD16+-CD56d'm+) express only the p75 IL-2R and mediate IL-2-dependent functions primarily through an intermediate affinity receptor is consistent with prior reports (1) (2) (3) (4) 11) . Co-expression of CD25 and p75 IL-2R on the CD16-CD56b°gh'+ NK cells suggested that these cells possess high affinity IL-2 receptors .
Differential response of CD16-and CD16' NK Cells to Low Concentrations of rIL-2 . CD16-and CD16' NK cells were isolated to >98% purity by cell sorting, incubated with various concentrations of rIL-2, and assayed for cytolytic activation and IL-2-dependent proliferation (Fig. 2) . Consistent with the presence of high affinity IL-2 receptors, CD16 -NK cells showed a significantly greater magnitude of IL-2-induced cytolytic activation and proliferation than CD16' NK cells. CD16-NK cells demonstrated potent cytolytic activation and proliferation at IL-2 concentrations as low as 9 IU/ml. CD16' NK cells required significantly higher concentrations of IL-2, consistent with intermediate affinity IL-2 receptors being the primary IL-2 signal-transducing structure on these cells.
IL-2 Binding Assays. IL-2 binding assays were performed to determine the number and affinity of the IL-2 receptors . Scatchard analysis demonstrated the presence of -1,200 high affinity (-25 pM kD) and -9,600 intermediate affinity (-2 nM kD) IL-2 receptors on CD16" NK cells (Fig. 3) . CD16' NK cells expressed only a single intermediate affinity IL-2 receptor of -1.9 nM kD (-9,000 sites per cell) . The IL-2 binding data thus substantiated the phenotypic and functional studies and defini- tively showed that the differential responsiveness of CD16-and CD16' NK cells to IL-2 is manifested through different affinity IL-2 receptors.
Effects of Anti-IL-2 Receptor mAbs on IL-2-dependent Functions. Experiments were undertaken to determine the effects ofblocking mAbs against p75 IL-2R and CD25 on IL-2-dependent functions of CD16 -and CD16+ NK cell subsets. As previously reported (11), mAbs against p75 IL-2R effectively blocked IL-2 activation ofCD16+ NK cells (Fig. 4, A, B) . Interestingly, although anti-CD25 mAb alone failed to affect IL-2-induced activation (as would be expected from the phenotypic and binding studies), anti-CD25 mAb slightly increased the inhibition observed with anti-p75 IL-2R mAb (Fig. 4, A, B) . These results suggest that functional high affinity receptors may be present in very low levels (undetectable by IL-2 binding assays or flow cytom- etry) on these cells and that neutralization requires the presence of both anti-p75 IL-2R and anti-CD25 mAb.
IL-2-induced cytolytic activation of CD16-NK cells was inhibited by the antip75 IL-2R mAb, but not by anti-CD25 mAb (Fig. 4 A) . A combination of both anti-p75 IL-2R and anti-CD25 mAbs was more effective than anti-p75 IL-2R mAb alone in inhibiting cytolytic activation . Surprisingly, neither anti-p75 IL-2R nor anti-CD25 mAb alone affected IL-2-dependent proliferation ofCD16-NK cells, whereas a combination ofboth mAb gave pronounced inhibition (Fig. 4 C) . Previous studies have shown that these mAbs against CD25 and p75 IL-2R are effective in inhibiting binding of IL-2 to the high affinity receptor (5). Since CD16-NK cells express high affinity IL-2 receptors presumably consisting of a p75/p55 complex, it was surprising that high concentrations (20-30 ug/ml) ofthese mAbs individually had no significant effect on IL-2-induced proliferation. Similar results have recently been reported for mAb blocking of IL-2-dependent proliferation of T cell lines expressing both intermediate and high affinity IL-2 receptors (5, 6). Relative affinity and binding kinetics of the mAb versus ligand may account for these results. Recently, it has been shown that a substantial proportion of peripheral blood CD4 + T lymphocytes express low levels of CD25 (15); however, these T cells usually express only low affinity IL-2 receptors, lack p75 IL-2R, and are unresponsive to IL-2 (5, 6, 11, and Phillips, J. H., unpublished observation) . Therefore, the CD16-NK cell subset represents the only consistently detectable population of lymphocytes in peripheral blood ofnormal adults that constitutively expresses high affinity IL-2 receptors in vivo. Based on an extensive study of these cells, we have suggested that CD16 -NK cells may represent a peripheral blood progenitor population for mature CD16+ NK cells (13) . If this is the case, the presence of high affinity IL-2 receptors may allow expansion and differentiation of these cells with physiological concentrations of IL-2. Alternatively, CD16 -NK cells may represent a distinct NK subset that constitutively expresses high affinity IL-2 receptors as a consequence of activation in vivo. Nonetheless, the presence of high affinity IL-2 receptors would permit preferential responsiveness of CD16-NK cells in patients treated with rIL-2 for therapeutic purposes . Recent studies have shown a pronounced expansion of the CD16-NK cell subset in the peripheral blood of cancer patients after in vivo rIL-2 therapy (16, 17) . During normal immune responses, CD16-NK cells may respond to IL-2 produced in vivo by T cells after antigenic stimulation . CD16-NK cells have been shown to transcribe TNF-a and granulocyte/macrophage CSF (GM-CSF) after activation with IL-2 in vitro (13) . If this occurs in vivo, these cells may be an important source of cytokine production in physiological situations .
Summary
The majority of human NK cells express low affinity IgG Fc receptors (CD16+), whereas a minor subset of NK cells lack Fc receptor expression (CD16 -). In contrast to CD16 + NK cells that express only p75 IL-2 receptors, CD16-NK cells constitutively co-express both p75 and p55 IL-2 receptors in vivo and preferentially respond to low concentrations ofIL-2 with increased cytolytic activation and prolifer- 
